[Skip to Content]
[Skip to Content Landing]
Views 1,996
Citations 0
Editor's Note
July 8, 2019

Clinical Trial Evidence for the Real World

Author Affiliations
  • 1Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
  • 2Department of Geriatrics, University of California, San Francisco
JAMA Intern Med. 2019;179(10):1333-1334. doi:10.1001/jamainternmed.2019.1500

It has been repeatedly demonstrated that participants in randomized clinical trials (RCTs) do not look like the patients we treat in our clinical practices. The inclusion and exclusion criteria of most RCTs exclude older adults and those with more severe disease, as well as those with conditions such as renal disease, liver disease, and cancer. The article by Smyth et al1 in this issue of JAMA Internal Medicine raises 2 noteworthy considerations. First, the study starkly contrasts the population of patients enrolled in RCTs with those in the real world who are undergoing dialysis. After systematically reviewing the literature, not only do Smyth et al1 show that RCT participants were significantly younger, more likely to be male, and less likely to have diabetes or diabetic nephropathy when compared with the patients undergoing dialysis in the United States Renal Data System registry, but they show that their mortality risk is less than half than that of the registry patients. This finding has particular importance because patients undergoing dialysis often underestimate their disease prognosis, both because of uncertainty as well as optimism, as shown in another article in this issue of JAMA Internal Medicine by O’Hare et al.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words